Global Ovulation Test Market Size, Share, Forecast Report, 2020-2027

Ovulation is the process that results in the release of eggs from the ovary. The ovulation test detects a rise in luteinizing hormone (LH) in the urine. A rise in this hormone signals the ovary to release the egg. There is an increase in the demand of ovulation test kits across the globe. Urine test segment accounts for the largest market share due to its extensive application by women for testing pregnancy. Pregnancy management, women and child health gaining importance throughout the world favor the growth of this market. Increase in first pregnancy, complications during pregnancy and demand of reliable technology for pregnancy test kits. Home care segment is the largest segment for this market. The market is also driven by the demand of ovulation test kits giving 99% accurate results confirming pregnancy. The global market of Ovulation Test is expected to reach US$ 2500 million in 2023 from US$ 1000 million in 2016 with a CAGR of approximately 4.5% during the forecast period 2017-2023.
Key Players for Ovulation Test Market:

Some of the key players in this market are: Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co. Inc. (U.S.), Prestige Brands Holdings Inc. (U.S.), HiLin Life Products Inc. (U.S.) and Fairhaven Health LLC (U.S.)

Other players in this market are: Fertility Focus Limited (U.K.), Geratherm Medical AG (Germany), Accuquik (California), NecLife (India) and Piramal Healthcare (India)

Segments:

Global Ovulation Test market has been segmented on the basis of type of test which includes Urine Based Test, Saliva Based Test and other tests. The end users are Hospitals, clinics, diagnostic centers, fertility centers, home care, and others.